NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001809

Registered date:01/04/2009

To evaluate the efficacy and safety of KP-496NS for patients with perennial allergic rhinitis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPerennial allergic rhinitis
Date of first enrollment2009/04/01
Target sample size150
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Placebo KP-496NS 0.1% KP-496NS 0.3%

Outcome(s)

Primary OutcomeNasal symptom score, rhinoscopic findings, side effects
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximum65years-old
GenderMale and Female
Include criteria
Exclude criteria(1) Patients having diseases that could interfere with assessment of treatment (2) Patients are/having recieved treatment for diseases that could interfere with assessment of treatment (3) Patients with bleeding tendency (4) Patients with problems in safety

Related Information

Contact

public contact
Name
Address 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo 113-8650, Japan Japan
Telephone
E-mail
Affiliation KAKEN PHARMACEUTICAL CO., LTD. Clinical Development Department
scientific contact
Name Shunkichi Baba
Address 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya City, Aichi, Japan, 467-8601 Japan
Telephone
E-mail
Affiliation Graduated school of Medicine, Nagoya City University, emeritus professor Department of Otorhinolaryngology